Cryptococcal Meningitis Treatment Guidelines

Standard Induction Regimen

The Infectious Diseases Society of America (IDSA) recommends liposomal amphotericin B at 3-4 mg/kg/day for 2 weeks (14 days), yielding a total cumulative dose of 42-56 mg/kg, with B-II evidence for HIV-infected patients and B-III evidence for transplant recipients 1, 2
The standard induction regimen should be combined with flucytosine (100 mg/kg/day) for optimal outcomes 1, 2
The calculation for standard dosing is: 3 mg/kg/day × 14 days = 42 mg/kg total cumulative dose 1, 2
The calculation for standard dosing is: 4 mg/kg/day × 14 days = 56 mg/kg total cumulative dose 1, 2

When flucytosine is not available or the patient is intolerant, extend liposomal amphotericin B to 4-6 weeks at 3-4 mg/kg/day, resulting in a total cumulative dose of 84-168 mg/kg 1, 2
The calculation for extended dosing is: 3 mg/kg/day × 28 days = 84 mg/kg total cumulative dose 1, 2
The calculation for extended dosing is: 4 mg/kg/day × 28 days = 112 mg/kg total cumulative dose 1, 2
The calculation for extended dosing is: 3 mg/kg/day × 42 days = 126 mg/kg total cumulative dose 1, 2
The calculation for extended dosing is: 4 mg/kg/day × 42 days = 168 mg/kg total cumulative dose 1, 2

For patients with high fungal burden, treatment failure, or transplant recipients with severe disease, consider liposomal amphotericin B at 6 mg/kg/day for 4-6 weeks, yielding a total cumulative dose of 168-252 mg/kg 3
The calculation for high-dose regimen is: 6 mg/kg/day × 28 days = 168 mg/kg total cumulative dose 1, 3
The calculation for high-dose regimen is: 6 mg/kg/day × 42 days = 252 mg/kg total cumulative dose 1, 3

Transplant recipients require the standard 2-week induction with liposomal amphotericin B 3-4 mg/kg/day (42-56 mg/kg cumulative) due to concerns about nephrotoxicity from concurrent calcineurin inhibitors 1, 2
HIV-infected patients should receive the standard 2-week induction (42-56 mg/kg cumulative dose) followed by fluconazole consolidation at 400 mg/day for 8 weeks, then maintenance at 200 mg/day for at least 1 year 1, 2, 4, 5
Antiretroviral therapy should be delayed 2-10 weeks after starting antifungal treatment to minimize immune reconstitution inflammatory syndrome (IRIS) risk 1, 2, 3, 5

Monitor serum creatinine, electrolytes (particularly potassium and magnesium), and complete blood counts throughout therapy 4
Perform serial lumbar punctures to document CSF sterilization and manage elevated intracranial pressure aggressively 4, 5
If using flucytosine, monitor serum levels (target: 30-80 μg/mL) and adjust for renal function 4, 5

Do not use liposomal amphotericin B monotherapy for only 2 weeks without flucytosine unless extending to 4-6 weeks 1, 2
Do not start antiretroviral therapy immediately in HIV patients; wait 2-10 weeks to reduce IRIS risk 1, 2, 3, 5
Do not rely on cryptococcal antigen titers to guide treatment duration; use clinical response and CSF sterilization 6, 5
Do not underestimate the importance of managing elevated intracranial pressure, which requires aggressive therapeutic lumbar punctures 4, 5